David Massicotte‐Azarniouch

University of North Carolina at Chapel Hill

ORCID: 0000-0002-6954-2030

Also affiliated with Ottawa Hospital, Ottawa Hospital Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis”.

Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac337

N/A

0DataRank · unranked

12 citations

Randal K. Detwiler, Yichun Hu, Ronald J. Falk, Manish K. Saha, Susan L. Hogan +2 more

Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis

American Journal of Kidney Diseases(2023)10.1053/j.ajkd.2023.10.016

N/A

0DataRank · unranked

2 citations

Randal K. Detwiler, Yichun Hu, Ronald J. Falk, Manish K. Saha, David van Duin +3 more

Novel Treatment Paradigms: Complement Inhibition in Antineutrophil Cytoplasmic Autoantibody Vasculitis

Kidney International Reports(2025)10.1016/j.ekir.2025.07.015

N/A

0DataRank · unranked

2 citations

David Massicotte‐Azarniouch, Donna O. Bunch, Dhruti P. Chen, J. Charles Jennette, Ronald J. Falk +1 more